Curiox BioSystems Co

Curiox BioSystems Co Net Debt per Share

The Net Debt per Share of Curiox BioSystems Co (445680.KQ) as of Oct 26, 2026 is -1,054.49 KRW. In the previous year, Net Debt per Share was -518.68 KRW — a change of 103.30% (lower).

Net Debt per Share

-1,054.49KRW

YoY

103.30%

Last updated:

Net Debt per Share of Curiox BioSystems Co is 2023 -1,054.49 KRW. Net Debt per Share of Curiox BioSystems Co was 2022 -518.68 KRW. It decreases by 103.30% lower compared to the previous year.

The Curiox BioSystems Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2021
-212.02 KRW
Jan 1, 2022
-518.68 KRW
Jan 1, 2023
-1,054.49 KRW
The Curiox BioSystems Co Net Debt per Share history
YEARNet Debt per ShareYoY
-1,054.49KRW+103.30%
-518.68KRW+144.63%
-212.02KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Curiox BioSystems Co Stock analysis

What does Curiox BioSystems Co do? Curiox BioSystems Co Ltd generates revenue through the manufacture and sale of automation equipment and consumables for cell analysis processes. The company offers cell pretreatment automation devices, washing machines, and plates, alongside high-capacity adapters, strip spacers, and buffer exchanger products. These products are sold to customers in the Life Sciences Tools & Services industry, primarily within the Korean market. The firm's focus on automation solutions for cell analysis drives its product portfolio and customer base. The company's product lines include cell pretreatment automation devices, washing machines, plates, high-capacity adapters, strip spacers, and buffer exchanger products. These items are designed for use in cell analysis processes, targeting clients who require efficient and precise laboratory equipment. The sales of these specialized tools form the core of Curiox BioSystems' revenue streams. Curiox BioSystems operates within the Life Sciences Tools & Services industry, focusing on providing automation solutions for cell analysis. Its products are manufactured and sold directly to end-users in the life sciences sector, including research institutions and laboratories. The company's revenue is derived from the direct sale of its equipment and consumables without intermediaries. Curiox BioSystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curiox BioSystems Co stock

Net Debt per Share of Curiox BioSystems Co is -1,054.49 KRW in 2023.

Net Debt per Share of Curiox BioSystems Co changed from -518.68 KRW to -1,054.49 KRW, representing a 103.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Curiox BioSystems Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Curiox BioSystems Co

All Key Metrics — Curiox BioSystems Co